Brain. Sci. 2012, 2(4), 684-708; doi:10.3390/brainsci2040684

Review
Physical Activity, Cognitive Function, and Brain Health: What Is the Role of Exercise Training in the Prevention of Dementia?
Sara M. Gregory *, Beth Parker and Paul D. Thompson
Department of Preventive Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA; Email: bparker03@harthosp.org (B.P.); pthomps@harthosp.org (P.D.T.)
*
Author to whom correspondence should be addressed; Email: sgregory@harthosp.org; Tel.: +1-860-545-4759; Fax: +1-860-545-2882.
Received: 23 August 2012; in revised form: 22 October 2012 / Accepted: 13 November 2012 /
Published: 29 November 2012

Abstract

: The population of elderly adults in the US is growing, and the prevalence of age-related cognitive decline and dementia is expected to increase in turn. Effective and inexpensive interventions or preventive measures are necessary to attenuate the increased economic and social burden of dementia. This review will focus on the potential for physical activity and exercise training to promote brain health and improve cognitive function via neurophysiological changes. We will review pertinent animal and human research examining the effects of physical activity on cognitive function and neurophysiology. We will discuss cross-sectional and longitudinal studies addressing the relationship between neurocognitive health and cardiorespiratory fitness or habitual activity level. We will then present and discuss longitudinal investigations examining the effects of exercise training on cognitive function and neurophysiology. We will conclude by summarizing our current understanding of the relationship between physical activity and brain health, and present areas for future research given the current gaps in our understanding of this issue.
Keywords:
cognitive function; hippocampus; exercise; fitness; dementia

1. Introduction

The elderly population in the United States is expected to increase dramatically by mid-century. US Census Bureau projections estimate that the population of US residents over age 65 will more than double between 2008 and 2050, and 1 in 5 US residents will be over the age of 65 by 2030 [1,2] (Figure 1). A progressively older population increases the social and economic burdens required to care for the physiological consequences of the aging process, including the structural and functional changes in the brain associated with a decline in cognitive function [3]. Age-related cognitive changes may progress from mild cognitive impairment (MCI) to dementia—a condition in which memory, behavior, and cognition are impaired secondary to neurodegeneration in the brain. Alzheimer’s disease (AD) is diagnosed when these neurodegenerative brain changes prevent an individual from performing basic physical tasks and bodily functions [4]. It is estimated that 5.4 million people suffer from AD in 2012 (5.2 million over the age of 65) and healthcare costs related to AD are estimated at between $130 and $200 billion in the US [4,5]. These costs are projected to reach $1.1 trillion by 2050. As the elderly population grows, the healthcare-related financial burden will increase, and the need for pharmacological and non-pharmacological prevention and treatment for these conditions increases. This review of literature will discuss the potential for regular physical activity to maintain cognitive function and normal neurophysiology, and prevent the progression from mild cognitive impairment to dementia.

Brainsci 02 00684 g001 1024
Figure 1. Prevalence (2010) and projected population estimates in 2030 and 2050 for the number of US adults over age 65, with Alzheimer’s dementia, and with cognitive impairment based on US Census Bureau population projections.

Click here to enlarge figure

Figure 1. Prevalence (2010) and projected population estimates in 2030 and 2050 for the number of US adults over age 65, with Alzheimer’s dementia, and with cognitive impairment based on US Census Bureau population projections.
Brainsci 02 00684 g001 1024

2. Aging and Brain Integrity

Normal aging is associated with structural and neurophysiological changes in the brain as well as a decline in cognitive function. Age has been correlated with a loss of cerebral cortical tissue, most consistently in the frontal cortex and hippocampus. Age has also correlated with a loss of white matter in the frontal, occipital, temporal, and parietal regions and cerebellum [6]. A longitudinal analysis of adults age 64 to 86 (120 normal and 18 with MCI) showed a decline over 10 years in brain volume of all regions scanned by magnetic resonance imaging (MRI) [3]. Some areas were reported to show accelerated decline with aging, which included the ventricular cerebrospinal fluid (CSF), frontal gray matter, and areas of the frontal and parietal lobes. Volume losses in the ventricular CSF, gray matter, hippocampus, orbitofrontal, middle temporal, and perirhinal cortices were greater over 10 years in subjects with MCI [3]. Hippocampal volume loss in elderly subjects may be related to cognitive impairments. Elderly subjects (age 60–85) demonstrated impaired memory task performance, smaller hippocampal volumes, and lower n-acetylaspartate/creatine (NAA/Cr) ratios in the frontal white matter and hippocampus when compared to young subjects (age 20–39) [7]. Hippocampal volume and NAA/Cr ratio correlated with performance on cognitive tasks in elderly subjects [7]. NAA is a brain-specific metabolite involved in myelin turnover and the NAA/Cr ratio is considered an indicator of neuronal health with lower ratios indicating neurodegeneration [8]. Thus, brain tissue atrophy and neurophysiological changes occur with aging and may be related to changes in cognitive function.

The age-related loss of brain tissue and neurophysiological changes appears to be region-specific. The hippocampus has been studied intensively because of its role in facilitating memory-related tasks. Blood flow measured by positron emission tomography (PET) increased to the medial temporal lobe, which includes the hippocampus, during episodic memory recall in middle-aged subjects [9], and hippocampal volume was associated with performance on tests of memory-related cognitive function [7,10]. The functional importance of the hippocampus is evidenced by reports of impaired performance on spatial memory tasks in rats with hippocampal lesions and in humans with hippocampal resections [11,12]. Furthermore, a 9-year, prospective study demonstrated that greater gray matter volume in the hippocampus, frontal gyrus, and supplementary motor area was associated with a lower risk of developing MCI [13]. Hippocampal atrophy, which occurs normally with aging, may be accelerated in those who progress from mild cognitive impairment (MCI) to dementia [10,14]. These findings suggest that interventions aimed at preventing hippocampal atrophy and neurodegeneration may prevent age-related cognitive/memory impairments and associated structural and function brain changes.

3. Exercise Training and Cognitive Function

3.1. Animal Studies

Several animal models of physical activity and exercise training have demonstrated beneficial effects on cognitive function. Daily wheel running for 2 weeks [15] or increased physical exercise for 7 weeks [16] improved memory and learning performance in mice, although cognitive stimulation was also provided to the animals that had exercised in the latter study. A combination of physical and cognitive activities improved memory performance in rats when compared to either physical or cognitive activity alone and sedentary controls [17]. Furthermore, aerobically-trained middle-age and old mice performed better on tasks involving memory and learning than sedentary controls [18]. Similar improvements in memory and learning occurred after 5 days of wheel running [19] and 4 weeks of treadmill running [20] in mice.

In addition to cognitive improvement, animal models also report protective effects of exercise on cognitive function. Age-related impairments in memory and spatial learning were reversed by increased physical activity in older mice [21,22]. Similarly, chronic aerobic exercise maintained cognitive function in mice exposed to stress induced by cortisone administration or immobilization [21,22,23]. These collective findings indicate that physical activity may improve or reverse age- and stress-related impairment in hippocampal-related cognitive tasks (i.e., memory and learning), and provide the framework for the human studies that will be discussed below exploring the relationship between physical activity and cognitive impairment.

3.2. Human Studies

3.2.1. Cross-Sectional and Observational Investigations

Cross-sectional studies in humans suggest that more active individuals may have reduced risk of cognitive impairment and dementia [24,25,26,27,28]. Individuals that reported greater amounts of light exercise had a reduced odds ratio for all-cause and Alzheimer’s dementia when compared to those reporting no activity [29]. Cognitive impairment was more prevalent in those reporting no activity versus moderate and high activity levels in a community-based study of persons over 55 years [30]. Moreover, higher self-reported activity levels at mid- and late-life were associated with a reduced odd ratio for MCI in late life, and physical activity levels at various points across the lifespan (teenage, age 30, age 50, and age >65) were associated with reduced risk of cognitive impairment in older adults [25,31]. Self-reported history of high-intensity exercise was associated with better cognitive performance in those over 80 years, but worse cognitive performance in postmenopausal women [32,33]. Moderate activity levels, however, were correlated with better cognitive performance in postmenopausal women [33]. Older (>60 years) marathon runners and bicyclists performed better than inactive controls on only one cognitive task—the Five Point Test—of the Vienna Neurophysiological and Cerad Test Batteries [34]. A meta-analysis of 37 studies, including cross-sectional and longitudinal studies, concluded that increased physical activity was associated with better cognitive performance, although the average effect size was small and there was a wide range of effect sizes for individual studies (for example −1.08 to 2.56 for the relationship between physical activity and cognition in cross-sectional designs). These collective findings indicate that increased physical activity may improve cognition and/or reduce the likelihood of cognitive decline and dementia, but the effect may be small and variable.

Prospective longitudinal investigations have attempted to determine the effects of physical activity or fitness on cognitive decline or incident dementia over follow-up periods of several years (Table 1). Higher physical activity levels at baseline were associated with less cognitive decline over 2- to 8-year follow-up periods [25,26,27,28,30,35,36,37,38,39]. In a large prospective investigation, individuals in the middle and highest tertiles of cardiorespiratory fitness had a reduced risk for dementia-related mortality over an average follow-up period of 17 years when compared to the lowest tertile [26]. The most significant reduction in risk was seen between the lowest and middle fitness tertiles, and each 1-metabolic equivalent (MET) improvement in fitness reduced the relative risk of dementia-related mortality by 14%. Similarly, a meta-analysis of 16 prospective studies reported a reduction in relative risk for dementia in the highest physical activity category when compared to the lowest [40]. Comparison of cross-sectional and prospective analyses is made difficult by differences in the method used to measure physical activity level: questionnaire [27,28,35,39], self-reported activities [28,30,37], and more objective measures, including active energy expenditure [38], 24-h actigraphy [24], or cardiorespiratory fitness [26]. In addition, different activity status classifications have been used, such as dichotomizing the sample into active and inactive subjects based on arbitrary cut points [35,37,38], differentiating between levels of activity (i.e., low, moderate, and high) [30], or establishing percentiles [28,38,39]. Studies also differ in the outcome variable measured (i.e., cognitive performance, dementia development, Alzheimer’s risk or mortality) and measurement technique (i.e., cognitive test battery used, criteria for dementia or cognitive impairment). Such differences make it difficult to compare studies and draw firm conclusions.

Table Table 1. Summary of cross-sectional and observational studies regarding physical activity, fitness, and brain function.

Click here to display table

Table 1. Summary of cross-sectional and observational studies regarding physical activity, fitness, and brain function.
StudyNFitness/Activity IndicatorPrimary Outcome VariablePrimary Finding
Erickson et al. 2010 [13]299Physical activity level measured at baseline as blocks walked per weekGray matter volume (GMV) at 9-year follow-up visitWalking distance predicted GMV 9 years later. Areas included frontal, parietal, and occipital lobes, entorhinal cortex, and hippocampus.
Buchman et al. 2012 [24]716Total daily physical activity (PA) based on 24-h actigraphy for 10 daysIncidence of Alzheimer’s dementia and cognitive decline (performance on battery of 19 cognitive tests) over 4 yearsDaily PA was associated with the risk of developing AD 1 based on Cox proportional hazards (individual in 10th percentile had >2-fold greater risk of AD than person in 90th), and was associated with the level and annual rate of decline in global cognitive function.
Geda et al. 2010 [25]1324Physical activity (determined by questionnaire) in mid- life (age 50 to 65) or late life (age 70-89)Odds of developing MCI 2 in later lifeThe odds ratio for development of MCI was lower for any frequency of moderate intensity physical activity performed in mid-life (OR = 0.61) and late-life (OR = 0.68).
Liu et al. 2012 [26]14,811 women and 45,078 men (age 20 to 88)Cardiorespiratory fitness (CRF)-peak MET 3 level achieved on graded treadmill testRisk of dementia-related mortality over an average follow-up period of 17 yearsIndividuals in the top and highest CRF tertile had lower risk for dementia-related mortality. The relative risk of dementia-related mortality decreased 14% for each 1 MET increase in fitness.
topton et al. 2008 [27]7595“High” vs. “Low/No” exercise based on response to two questions on a self-administered questionnaire Cognitive decline based on performance on Modified Mini-Mental State Examination (mMMSE)High exercisers showed less cognitive decline (3.1 vs. 5.5 pts on mMMSE over 5 years) when compared to low/no exercisers. Higher levels of exercise were associated with a lower risk of cognitive decline (10.3% vs. 15.8%) and a greater probability of cognitive improvement or stability (89.7 vs. 84.2%).
Yaffe et al. 2001 [28]5925Physical activity level measured by self-reported number of blocks walked or flights of stairs ascended per day and by the Paffenbarger Scale via interviewCognitive decline (≥3 point decrease on mMMSE) at 6 and 8-year follow-upsOdds of developing cognitive decline were 37% lower in the higher quartile of blocks walked (odds ratio, OR = 0.63) and 35% lower in the highest quartile of kcal expended (OR = 0.65).
Andel et al. 2008 [29]264 dementia cases (2870 controls); 90 AD-discordant twin pairs Self-reported physical activityRisk for dementia developmentLight exercise was associated with a reduced odds ratio of dementia (all-cause and Alzheimer’s) in case-control analyses. There was a non-significant reduction in odds ratio of dementia with higher activity levels in twin analyses.
Etgen et al. 2010 [30]3903Physical activity level (no, moderate, or high activity) based on self-reported activitiesCognitive performance measured using the 6CIT (higher score indicates more cognitive impairment) at baseline and 2-year follow-upAt baseline, 6CIT 4 scores were higher in no activity group compared with moderate and high activity. Cognitive impairment was more prevalent in the no activity (21.4%) compared to moderate (10.5%) and high (7.3%) activity groups. Moderate and high activity groups had reduced risk for cognitive impairment. No activity group had greater incidence of new cognitive impairment over 2 years compared to active groups.
topton et al. 2010 [31]9344Self-reported physical activity in teenage years, age 30, age 50, and late life (over 65). Classified as either inactive or inactiveCognitive impairment determined by mMMSE score (impairment = score at least 1.5 standard deviation below the mean)Physically active women at each age were less likely to have cognitive impairment in late life. Teenage physical activity status was most strongly related with reduced odds of late-life cognitive impairment.
Landi et al. 2007 [32]364Self-reported physical activity on questionnaire item related to frequency of high and light physical activityCognitive performance (Cognitive Performance Scale)Those with a history of high-intensity physical activity had improved cognitive performance regardless of the age at which it was performed.
Tierney et al. 2010 [33]90Self-reported physical activity between high school and menopausePostmenopausal cognitive performance (scores derived from a series of cognitive tests) A positive relationship existed between moderate intensity activities and cognitive performance. A negative relationship existed between strenuous physical activities and cognitive performance.
Winker et al. 2010 [34]114Elderly marathon runners were compared to inactive controlsCognitive performance (Vienna Neurophysiological Test Battery and CERAD 5 test battery) Marathoners performed better in only one cognitive task (Five Point Test).
Arntzen et al. 2011 [35]5033Self-reported PA 6-classified as active or inactive based on 2 questionnaire items Cognitive performance at 7-year follow-upPA was associated with better cognitive performance in women, but not men.
Larson et al. 2006 [37]1740Self-reported physical activity (classified as physically active if they exercised at least 3 times per week)Change in cognitive performance (using CASI 7) and incidence of dementia at biennial assessments over 6 yearsRegular exercisers had a lower incidence rate of dementia (13.0 vs. 19.7 versus 1000 person-years), a higher probability of being dementia-free, and a lower age- and sex-adjusted risk of dementia compared to those exercising less than 3 times per week.
topton et al. 2011 [38]197Activity energy expenditure (AEE, measured using doubly labeled water)Incidence of cognitive decline (based on mMMSE) over ~5 year follow-upLevels of AEE were strongly associated with the likelihood of incident cognitive impairment (1.5% in highest tertile, 4.5% in the top, and 16.9% in the lowest). The top and highest tertiles were less likely to have incident cognitive impairment than the lowest tertile based on odds ratio.
Weuve et al. 2004 [39]7982Self-reported physical activity from Nurse’s Health Study questionnaires Baseline cognitive function (Telephone Interview for Cognitive Status) and decline in cognitive function over 2 years Those with highest physical activity levels at baseline had 20% lower odds of cognitive impairment compared to lowest quintile. Higher levels of physical activity were associated with less decline in most measures of cognitive performance.
Erickson et al. 2009 [41]165Cardiorespiratory fitness (CRF; VO2 peak 8)Hippocampal volume and spatial memory taskCRF was a significant predictor of right and left hippocampal volume (HV), and modestly associated with performance on a memory task. Left HV was a significant partial mediator between fitness and spatial memory.
Erickson et al. 2012 [42]137Cardiorespiratory fitness (VO2peak)Creatine and NAA 9 levels in the brain (MRS 10); cognitive performance (spatial memory and digit span task)Age X fitness interaction indicated that aerobic fitness offset the age-related decline in NAA in the frontal cortex.
Honea et al. 2009 [43]117Cardiorespiratory fitness (VO2peak)Regional brain volumes and associations with CRF in non-demented and mild AD patientsAtrophy was reported in the medial temporal, temporal, and parietal cortices in the mild AD group. CRF was associated with parietal and medial temporal volumes in mild AD patients but not non-demented adults. Apo ε4 genotype did not affect the relationship.

1 AD = Alzheimer’s-type dementia; 2 MCI = mild cognitive impairment; 3 MET = metabolic equivalent; 4 6CIT = 6 Item Cognitive Impairment Test; 5 CERAD = Consortium to Establish a Registry for Alzheimer’s Disease; 6 PA = physical activity; 7 CASI = Cognitive Abilities Screening Instrument; 8 VO2peak = peak oxygen consumption during graded exercise; 9 NAA = n-aceytlaspartate; 10 MRS = magnetic resonance spectrometry.

Although cross-sectional and prospective analyses provide data supporting a relationship between physical activity and cognitive function, they do not allow determination of a cause and effect relationship between exercise training and brain health. Interpretation of research findings is complicated by the questionable accuracy and reliability of self-reported physical activity, especially in the elderly population at risk for cognitive impairment. Other inherent faults in cross-sectional studies are the heterogeneous methods for measuring and quantifying physical activity, fitness level, and cognitive impairment, and the likeliness of a bidirectional relationship between cognitive impairment and physical activity. Investigations measuring cardiorespiratory fitness by maximal oxygen consumption (VO2peak) [26,41,42] have the advantage of presumably assessing physical activity level by more objective and reliable methods when compared to retrospective activity questionnaires or recall methods. The results of these investigations may therefore provide more reliable evidence of the relationship between physical activity and brain health. It is important to consider that although cardiorespiratory fitness logically relates to activity level, it is not necessarily reflective of activity levels, as cardiorespiratory fitness can be influenced by other factors such as chronic disease [44,45], especially in older, untrained populations. Moreover, the relationships reported may simply describe the likelihood that those with cognitive impairment and increased dementia risk are also those most likely to have physical limitations, chronic disease, or psychological issues that reduce their activity level and/or measured cardiorespiratory fitness. Furthermore, physical impairments that limit mobility may reduce access to social interaction with family and peers, which may influence cognitive function.

3.2.2. Interventional Studies

Research designs employing exercise interventions (Table 2) provide the ability to examine a cause and effect relationship between exercise training and cognitive function. A recent meta-analysis of 29 studies involving aerobic exercise interventions reported modest but significant improvements in attention and processing speed, executive function, and memory in exercise-trained subjects [46]. Improvements in cognitive performance have been reported after supervised [47,48] and non-supervised [49] exercise interventions. In the latter, the exercise group, which was unsupervised but encouraged to increase their current physical activity level by 150 min per week for 18 months, improved performance on delayed recall and on the cognitive section of the Alzheimer Disease Assessment Scale (ADAS-cog) [49]. Improvements in the ADAS-cog and delayed recall occurred in the whole exercise group and also among those exercisers with MCI at baseline. In contrast, cognitive performance did not improve in previously sedentary, cognitively normal elderly subjects after an exercise intervention primarily involving walking for 150 min per week, although improvements in cognitive performance were correlated with improvements in physical performance [50].

Table Table 2. Summary of interventional studies that examined physical activity, fitness, and brain function. (A) includes studies that examined brain volumes; (B) includes studies that examined only cognitive function.

Click here to display table

Table 2. Summary of interventional studies that examined physical activity, fitness, and brain function. (A) includes studies that examined brain volumes; (B) includes studies that examined only cognitive function.
(A)
StudyIntervention/SubjectsCognitive FunctionLeft Hippocampal volumeRight Hippocampal Volume
Erickson et al. 2011 [51] (n = 120)1 year: Walking 3 days per week vs. stretching/toning control groupBoth groups improved spatial memory task performance.Increased 2.12% in exercise group. Decreased 1.4% in the control group.Increased 1.97% in exercise group. Decreased 1.43% in control group.
Elderly adults without dementia (age 55–80)Greater fitness improvements were associated (r = 0.37) with greater changes in hippocampal volume. Higher fitness level at baseline was associated with less hippocampal volume loss in the control group.
Colcombe et al. 2006 [52] (n = 59)6 months: aerobic walking 3 days per week vs. stretching/toning control group and non-exercising young controlsNot assessedThe aerobic exercise group showed an increase in gray matter (mainly frontal cortex) and white matter (anterior white matter tracts). Subjects in the aerobic training group had an average relative risk reduction for brain volume loss of 42.1%, 33.7%, 27.2%, and 27.3% in the anterior cingulate cortex, right superior temporal gyrus, right middle frontal gyrus, and anterior white matter clusters. The non-exercising young control group showed no change in brain volume.
Older adults (age 60–79) and group of young controls (age 18–30)
Pajonk et al. 2010 [53] (n = 24)3 months: cycling for 30 min on 3 days per week vs. non-exercise group that performed table tennis and exercise group of normal subjectsMemory improved in the schizophrenic exercise group more than the non-exercise group and the normal control group.Hippocampal volume increased by approximately 14% in the combined exercise group: 12% increase in the schizophrenic group and 16% increase in the healthy control group. The change in relative hippocampal volume was related to the change in aerobic fitness in exercised schizophrenic and healthy control groups.
Schizophrenic individuals and healthy, normal controls (age 20–51)
Parker et al. 2011 [54] (n = 13)10 weeks: 3 days per week aerobic activity. No control groupSome improvements on computerized figural memory taskNo significant changeNo significant change
Healthy men and women (age 23–45)Change in aerobic fitness was correlated with change in right (r2 = 0.31) and left hippocampal volume (r2 = 0.41).
Liu-Ambrose et al. 2010 [55] (n = 155)1 year: Full-body RT 1 on 1 or 2 days per week vs. Thai Chi and balance exercise control groupStroop test performance improved by 12.6% and 10.9% in the 1/week and 2/week RT groups (0.5% decline in the control group)Both RT groups showed a decrease in whole brain volume (−0.02% and −0.04% at 6 months; −0.43% and −0.32% at 1 year) with no change in control group
Women aged 65–75 without dementia
(B)
StudyIntervention/SubjectsCognitive Function
Baker et al. 2010 [46] (n = 33)6 months: aerobic exercise 4 days per week vs. stretching control groupExecutive function (multitasking, cognitive flexibility, information processing efficiency, and selective attention), but not short-term memory, improved in the exercise group compared to the control group.
Sedentary males and females (age 55–85) diagnosed with amnestic MCI
Baker et al. 2010 [47] (n = 28)6 months: aerobic exercise 4 days per week vs. stretching control groupExecutive function, but not short-term memory, improved in the exercise group compared to the control group.
Adults (age 56–83) with impaired glucose tolerance
Lautenschlager et al. 2008 [48] (n = 170)18 months: Active group increased aerobic activity to 150 min per week (three 50 min sessions per week) vs. control group that did notSubjects in the active group improved ADAS-cog and delayed recall scores more than the control group after 18 months.
Men and women over age 50 (102 with MCI 2)
Williamson et al. 2009 [49] (n = 102)1 year: physical activity intervention (primarily walking) or health education programThere were no differences in cognitive scores between groups after the intervention. Cognitive performance was correlated with changes in physical performance.
Sedentary elderly individuals without dementia (age 70-89)
Cassilhas et al. 2007 [56] (n = 62)24 weeks: full-body RT 3 days week at moderate-intensity (50% 1-RM 3) or high-intensity (80% 1-RM)Both RT groups improved neurophysiological test performance when compared to the control group.
Sedentary males age 65-75 years
Perrig-Chiello et al. 1998 [57] (n = 46)8 weeks: full-body RT 1 day per week vs. control groupImprovements in the training group were seen in free recall (delayed) and recognition (immediate and delayed).
Men and women (age 65 to 95)
Kimura et al. 2010 [58] (n = 119)12 weeks: Progressive RT 3 days per week beginning at a 10-RM loadExecutive function test performance did not change in either group.
Men and women (over 65 years)

1 RT = resistance training; 2 MCI = mild cognitive impairment; 3 1-RM = 1-repetition maximum.

Improvements in cognitive function have also been reported from supervised aerobic training interventions. Previously sedentary older adults with mild amnestic cognitive impairment at baseline improved performance on a series of tasks related to executive processing, but not short-term memory, after 6 months of aerobic training (4 days per week at 75% to 85% heart rate reserve) [48]. The control group that performed stretching and balance exercises showed no improvements in cognitive function. The intervention successfully improved cardiorespiratory fitness measured by maximal oxygen consumption (VO2peak) in the training group (+11%) compared to the control group (−7%). Interestingly, the treatment effect was larger in women for several executive function tests implying gender differences may exist in the response to exercise training. The same research group reported improved executive function, but not short-term memory performance in older, cognitively normal adults with impaired glucose tolerance relative to a stretching control group after a 6-month aerobic training intervention [47]. Comparatively, spatial memory improved in cognitively normal, elderly men and women after 1 year of aerobic exercise training, however, similar improvements were reported in the control group that performed only stretching exercises. Higher aerobic fitness level was correlated with spatial memory performance at baseline and at the end of the study for the combined sample, but fitness improvements were not related to improvements in memory. Baseline fitness levels may therefore be an important factor to consider when designing exercise intervention studies [51]. Findings from cross-sectional and experimental analyses support the benefits of exercise training for improving and maintaining cognitive function as indicated by improved performance on tests of memory task and executive function, and reduced risk of cognitive decline and dementia-related mortality in fitter and more active individuals. Problems with available interventional studies include the use of different tests for cognitive function, variability in the exercise training program, and an inability to examine the effects of lifelong activity patterns on dementia risk and cognitive function.

4. Exercise and Neurobiological Changes

4.1. Animal Studies

Several studies in animals have examined changes in brain physiology in response to physical activity. In mice, expression of brain-derived neurotrophic factor (BDNF) increased in the hippocampus, and hippocampus and striatum, after level and downhill running, respectively [21]. Others have reported increased mRNA expression of neurotrophic factors [23,59], enhanced signaling in neurogenerative pathways [21], increased expression of neurotransmitters [20,59], and favorable changes in energy metabolism and neurodegenerative markers [60] in the hippocampus of exercised mice. Furthermore, aerobic exercise reduced inflammatory cytokines and oxidative stress [61,62], and increased antioxidant capacity [23] in mice hippocampi. Treadmill exercise also prevented impairment in cognitive function and deleterious neurochemical changes (e.g., oxidative stress, reduced neurotrophic factor levels, neurodegeneration) induced by proline or streptozotocin administration in rats [63,64]. These findings indicate that exercise improves possible mediators of age- and stress-related neurodegeneration, and suggest that anti-inflammatory and antioxidant effects as well as neurochemical alterations in the hippocampus and cortex could mediate putative changes in neurologic function induced by exercise in humans.

Compelling findings from animal studies also suggest exercise training may prevent or reverse age-related changes in brain tissue associated with dementia [59,65,66]. Hippocampal cell proliferation was greater, but there were no differences in neurogenesis between physically active and sedentary transgenic mice predisposed to AD [67]. The findings were the same for physically active mice raised in an environment enriched with cognitive activities. In comparison, both cell proliferation and neurogenesis were enhanced in the dendate gyrus of old mice after 45 days of running when compared to sedentary counterparts [68]. Similarly, running exercise restored hippocampaal neurogenesis and dendritic remodeling after cortisone administration [22], and exercise during midlife reduced glial and vascular markers of aging in old mice [69]. Collectively, these findings suggest that chronic exercise may be protective against age-related changes in neurobiology, including altered expression of neurotrophic factors and neurotransmitters, and enhanced or maintained neuronal proliferation and maturation in the hippocampus.

4.2. Human Studies

4.2.1. Cross-Sectional and Prospective Studies

Cross-sectional and prospective human investigations suggest a relationship between fitness/physical activity level and brain health. In a prospective analysis of older adults, physical activity level at baseline (measured as self-reported number of blocks walked per week) predicted gray matter volume changes over 9 years [13]. In cross-sectional analyses, aerobic fitness (VO2peak) was associated with gray matter volume and white matter integrity in females with relapsing-remitting multiple sclerosis [70] and with parietal and medial temporal volume in early-stage AD patients [43]. Moreover, cardiorespiratory fitness, measured by VO2peak, was a significant predictor of right and left hippocampal volume, explaining 7.8% and 12.2% of right and left hippocampal volume, respectively in a group of older adults age 59 to 81 years [41]. Higher aerobic fitness was associated with greater right and left hippocampal volumes, but only left hippocampal volume was reported to be a significant partial mediator of the relationship between aerobic fitness and memory. In addition to hippocampal volume, physical fitness was related to brain levels of NAA [41]. Age is associated with a decline in NAA concentrations in the frontal cortex, but this may be offset by higher fitness levels [42]. NAA concentrations were similar between high and low fitness groups (based on VO2peak) in middle-age subjects (age 58–65), but concentrations were greater in fitter when compared to less fit older subjects (age 66–80). These cross-sectional investigations indicate a relationship between higher aerobic fitness level, larger hippocampal volume, and improved neuronal health, and suggest that improvements in cognitive function with aerobic activity may be mediated by neurophysiological and structural changes in the brain.

4.2.2. Interventional Studies

Interventional studies indicate aerobic exercise training increases regional brain volumes. Regional gray and white matter volumes increased and relative risk of brain tissue loss decreased in older non-demented adults performing aerobic exercise training for 6 months when compared to a control group that performed stretching and toning exercises [52]. Hippocampal volume increased between approximately 2% to 16% in small samples of young, healthy subjects after aerobic exercise training [53,54]. In a large sample (n = 120) of cognitively normal older adults, left and right anterior hippocampal volumes increased after 1 year of aerobic exercise training (walking 4 days per week at 60%–75% HRR) [51]. Improvements were relative to a control group that performed toning and stretching exercises. However, the changes in left (+2.12% in aerobic vs. −1.40% in control) and right (+1.97% vs. −1.43%) hippocampal volumes were modest. In addition, the standard deviation for volume measurements was 3–4 fold larger than the reported mean difference (~0.15 cm3) between groups indicating that the treatment effect was not large and there may be considerable intra-individual variability in the response. The large variability in hippocamal volume measurements is likely attributable to the multitude of biological and environmental factors that influence human brain physiology (Figure 2).

Brainsci 02 00684 g002 1024
Figure 2. Schematic representing the numerous factors that modulate the relationship between brain function and physical activity.

Click here to enlarge figure

Figure 2. Schematic representing the numerous factors that modulate the relationship between brain function and physical activity.
Brainsci 02 00684 g002 1024

There appears to be a relationship between fitness improvements and hippocampal volume changes with exercise training. After 1 year of aerobic training, greater improvements in aerobic fitness (VO2peak) were moderately but significantly (p < 0.001) associated with greater changes in left (r = 0.37) and right (r = 0.40) hippocampal volumes. In addition, higher fitness level at baseline was associated with less loss of right anterior hippocampal volume in the control group that did not exercise [50]. Similarly, our group reported modest (r2 = 0.41) but significant (p = 0.02) associations between changes in cardiorespiratory fitness (VO2peak) and changes in left hippocampal volume after a 10-week aerobic exercise intervention (3 days per week for 40 min at a moderate intensity) in 13 healthy men and women (age 23–45) [54]. Right and left hippocampal volume did not change, which may be related to the heterogenous fitness improvements observed (change in VO2peak range: 0 to 22%). The relationship between changes in cardiorespiratory fitness and increased hippocampal volume suggest that a longer duration intervention more likely to induce more uniform and substantial improvements in fitness may increase hippocampal volume. Increased regional brain volumes in older adults occurred concomitant to significant improvements in aerobic fitness ranging from 8% to 16% [51,53]. Together these findings suggest that improvements in cardiorespiratory fitness may mediate the effects of exercise training on brain volume, and suggest that exercise interventions that result in greater fitness improvement will elicit greater changes in brain volume. However, such theories are speculative and conflict with two meta-analyses of cross-sectional and longitudinal studies examining physical activity and cognition, including a Cochrane review of 11 RCTs [71], which concluded that aerobic fitness changes did not mediate changes in cognitive performance (regional brain volumes not measured) [72].

4.2.3. Regional Brain Activity

Regional brain activity, measured by changes in the blood oxygen level dependent (BOLD) signal intensity during functional MRI, is altered in those at risk for AD [73,74], in declining MCI [75,76], and in diagnosed AD [74]. The nature of these changes is not well understood, but there appears to be hyperactivity in the medial temporal lobe during cognitive stimulation in the early stages of MCI, prior to the onset of dementia, that is thought to be a consequence of reduced neuronal efficiency [74,75]. As cognitive impairment progresses, hippocampal activation is reduced and there is a compensatory increased in activity in other regions, including the parietal regions [74,76]. Higher fit and aerobically trained groups demonstrated increased prefrontal and parietal cortical activity and decreased activity in the anterior cingulate gyrus during a flanker task designed to elicit activation in the frontal and parietal lobes [77]. Greater activity in a large neural network associated with memory and learning, including the hippocampus, was associated with individual cardiorespiratory fitness level before and after a 6-month cycling program, but only in a group that also performed spatial navigation training [78]. Improvements in cardiorespiratory fitness with training correlated with increased activity in the frontal cortex, the cingulate gyrus, the insula, and the parahippocampal gyrus. Changes in regional brain activity may be related to the previously discussed structural and neurophysiological changes in the brain and may contribute to the cognitive benefits of exercise training.

5. Resistance Training

Several studies have examined the effects of resistance or strength training on cognitive function. In rats, aerobic training (treadmill running) and resistance training (vertical ladder climbing) improved spatial memory task performance; however, training modalities were associated with divergent neurochemical changes in the hippocampus [79]. Improvements in cognitive function were reported in three randomized clinical trials (RCT) of elderly men and women after full-body resistance training programs lasting between 8 weeks and 1 year [55,56,57]. Improvements were independent of frequency (one or two sessions per week) [55] and intensity (moderate versus high-intensity) [56]. In contrast, 12 weeks of progressive resistance training (3 days per week) had no effect on executive cognitive function in another RCT of elderly subjects. Only one study assessed changes in brain volume, and reported a small reduction in whole brain volume after resistance training (−0.43 to −0.32%) [55]. These limited studies and their divergent results suggest that the relationship between chronic resistance training and brain function has not been adequately studied to draw conclusions.

6. Conclusions and Directions for Future Research

Cross-sectional, prospective, and interventional studies provide promising, but not consistent, findings supporting cognitive benefits from regular exercise. Specifically, exercise training and physical activity may maintain or improve performance on hippocampus-related tasks via increased volume or neurophysiological changes. There are major deficiencies in our current understanding of the relationship between physical activity and brain function including the following:

6.1. How Does Exercise Benefit Brain Function in Special Populations at Risk for Accelerated Brain Tissue Atrophy and Dementia?

Certain diseases place individuals at an increased risk for the development of dementia and neurodegenerative changes. Studies performed in type 2 diabetics have reported increased risk for dementia [66,80], impaired cognitive performance [81], and accelerated whole brain and hippocampal atrophy [81,82,83,84,85] when compared to non-diabetics. Most of these studies included diabetics being treated with oral anti-diabetic agents and/or insulin therapy and did not exclude subjects with diabetic complications including cardiac disease, hypertension, and vascular disease. Consequently, there have been divergent findings regarding dementia risk and neurophysiological changes in diabetics, possibly because of disparities in diabetes duration, medical therapies used, presence of complications, and the degree of glycemic control within subjects groups [81,83,86].

There is some literature supporting an increased risk for dementia as well as decreased volume and/or altered shape of the hippocampus in depressed older adults [87,88,89,90], and particularly in those who experience depressive symptoms in late-life [91]. The effects appear to be more pronounced in the left hemisphere [90,92,93] and left hippocampal volume is inversely related to the rate of cognitive decline in older depressed adults [92,93]. Other conditions associated with accelerated neurodegeneration and cognitive decline include obesity [94,95,96,97], hypertension [85,98], and prior cerebral hypoperfusion injury [99,100,101,102]. In addition, cancer patients and survivors may be susceptible to cognitive decline and neurodegeneration due to the effects of chemo-therapy [103,104]. Investigations are needed into the effects of habitual physical activity level and structured exercise interventions on the rate and extent of cognitive decline and neurodegeneration in these vulnerable populations.

6.2. How Does the Nature of the Exercise Intervention or Physical Activity Influence Cognitive Function and Brain Volume/Physiology?

Cross-sectional studies suggest those who maintain an active lifestyle better maintain cognitive function and brain tissue integrity [24,25,28,31,41,42,51]. Improved cognitive function and small changes in brain volume were reported after exercise interventions lasting between 6 months and 1 year [48,51,52]. It is unclear if this is a sufficient period of time to adequately assess neurobiological changes in response to exercise. Furthermore, it may be that maintaining an active lifestyle across the lifespan prevents or reduces some of the age-related changes in cognitive function and brain physiology rather than improving these factors per se. Longer-term exercise studies are necessary to determine if (a) exercise can reduce loss of brain tissue volume and cognitive decline with age and (b) long-term chronic exercise across the lifespan can maintain brain function and tissue integrity. In addition, it remains to be determined if activity initiated in late-life confers equivalent benefits to lifelong physical activity, and if the time point, or age, at which the intervention is initiated influences the effectiveness of the intervention.

Other questions that remain include if a threshold “dose” of exercise is necessary to see changes in brain function, specifically does the intensity, duration, or frequency of the exercise session matter? Furthermore, for how long will exercise-induced improvements persist after cessation of exercise training or during periods of reduced physical activity? Improved performance on only 1 of 4 cognitive tests was maintained 1 year after cessation of a 12-month resistance training program [105], but further research is necessary to determine if aerobic exercise training leads to lasting improvements in brain function. Answering these questions requires a series of investigations comparing different levels of exercise intensity, duration, or frequency. Dose-response determination is complicated by seemingly limitless combinations of training variables that can be prescribed. Finally, the effects of exercise modality on brain function have not been adequately studied. It remains to be clarified if physical activities requiring higher levels of motor complexity or that require more memory function will differentially impact cognitive function or brain physiology. Thus, it is necessary to compare relatively simple motor tasks, such as walking, with activities that are more complex, such as dancing, game playing, and resistance training.

6.3. How Does Physical Activity Interact with Certain Medications to Affect Brain Function and Physiology?

Certain medications may improve or impair cognitive performance and thus have synergistic or antagonist interactions with exercise training interventions. For example, some antiepileptic medications have been associated with improved (e.g., levetiracetam, tiagabine) or impaired (e.g., phenobarbital, primidone, carbamazepine, phenytoin, and topiramate) cognitive function [106]. There is also limited evidence of a relationship between anticholinergic medications and cognitive impairment [107]. Carriers of the ApoE epsilon-4 allele may be especially sensitive to cognitive effects of anticholinergic medications [108]. Conflicting reports exist regarding the relationship of statin usage, cognitive function, and dementia risk [109]. In a few studies and in select few patient reports, impaired memory and cognitive performance have been reported approximately 2 months after statin therapy initiation [110,111,112]. Others have reported no change [113] or improved [114,115,116] cognitive function with statin therapy. There are promising findings from animal and human studies that statins may prevent or attenuate pathological neural and vascular changes associated with vascular and Alzheimer’s dementia [117,118,119]; for reviews see [120,121,122]. The interaction between pharmacological therapy and physical activity in influencing neurobiology and cognitive function is a relatively unexplored area that deservers further attention.

In conclusion, current research suggests that active individuals and those prescribed structured exercise regimes demonstrate improved cognitive function and reduced brain atrophy and/or neurodegeneration, particulary in the hippocampus. The relationship between physical activity and brain function is complicated by a multitude of modifying factors, including stress, education, socioeconomic status, medications, diseases, cardiovascular risk factors, and other health behaviors that are nearly impossible to control in human studies (Figure 2). The potential for exercise training to delay or attenuate age-related decrements in cognitive performance and neurobiology is an important field of study because of the possible benefit to the health and independence of a growing elderly population and to the larger social and economic environment. Directions for future research include targeting vulnerable clinical populations, optimizing exercise training variables, and examining the synergistic relationship between pharmacological and non-pharmacological therapies.

Conflict of Interest

The authors declare no conflict of interest.

References

  1. Vincent, G.K.; Velkoff, V.A. US Census Bureau: Suitland, MD, USA, 2010.
  2. Bernstein, R.; Edwards, T. An Older and More Diverse Nation by Midcentury; US Census Bureau: Suitland, MD, USA, 2008.
  3. Driscoll, I.; Davatzikos, C.; An, Y.; Wu, X.; Shen, D.; Kraut, M.; Resnick, S.M. Longitudinal pattern of regional brain volume change differentiates normal aging from mci. Neurology 2009, 72, 1906–1913.
  4. Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2012, 8, 131–168, doi:10.1016/j.jalz.2012.02.001.
  5. Cognitive Impairment: A Call for Action, Now!; Center for Disease Control and Prevention: Atlanta, GA, USA, 2011.
  6. Jernigan, T.L.; Archibald, S.L.; Fennema-Notestine, C.; Gamst, A.C.; Stout, J.C.; Bonner, J.; Hesselink, J.R. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol. Aging 2001, 22, 581–594, doi:10.1016/S0197-4580(01)00217-2.
  7. Driscoll, I.; Hamilton, D.A.; Petropoulos, H.; Yeo, R.A.; Brooks, W.M.; Baumgartner, R.N.; Sutherland, R.J. The aging hippocampus: Cognitive, biochemical and structural findings. Cereb. Cortex 2003, 13, 1344–1351, doi:10.1093/cercor/bhg081.
  8. Moffett, J.R.; Ross, B.; Arun, P.; Madhavarao, C.N.; Namboodiri, A.M. N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog. Neurobiol. 2007, 81, 89–131, doi:10.1016/j.pneurobio.2006.12.003.
  9. Piolino, P.; Desgranges, B.; Hubert, V.; Bernard, F.A.; Matuszewski, V.; Chetelat, G.; Baron, J.C.; Eustache, F. Reliving lifelong episodic autobiographical memories via the hippocampus: A correlative resting pet study in healthy middle-aged subjects. Hippocampus 2008, 18, 445–459, doi:10.1002/hipo.20406.
  10. Kesslak, J.P.; Nalcioglu, O.; Cotman, C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology 1991, 41, 51–54.
  11. Astur, R.S.; Taylor, L.B.; Mamelak, A.N.; Philpott, L.; Sutherland, R.J. Humans with hippocampus damage display severe spatial memory impairments in a virtual morris water task. Behav. Brain Res. 2002, 132, 77–84, doi:10.1016/S0166-4328(01)00399-0.
  12. Ramos, J.M. Preserved learning about allocentric cues but impaired flexible memory expression in rats with hippocampal lesions. Neurobiol. Learn. Mem. 2010, 93, 506–514.
  13. Erickson, K.I.; Raji, C.A.; Lopez, O.L.; Becker, J.T.; Rosano, C.; Newman, A.B.; Gach, H.M.; Thompson, P.M.; Ho, A.J.; Kuller, L.H. Physical activity predicts gray matter volume in late adulthood: The cardiovascular health study. Neurology 2010, 75, 1415–1422, doi:10.1212/WNL.0b013e3181f88359.
  14. Eckerstrom, C.; Olsson, E.; Borga, M.; Ekholm, S.; Ribbelin, S.; Rolstad, S.; Starck, G.; Edman, A.; Wallin, A.; Malmgren, H. Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: The goteborgmci study. J. Neurol. Sci. 2008, 272, 48–59, doi:10.1016/j.jns.2008.04.024.
  15. Van der Borght, K.; Havekes, R.; Bos, T.; Eggen, B.J.; van der Zee, E.A. Exercise improves memory acquisition and retrieval in the Y-maze task: Relationship with hippocampalneurogenesis. Behav. Neurosci. 2007, 121, 324–334.
  16. Vedovelli, K.; Silveira, E.; Velho, E.; Stertz, L.; Kapczinski, F.; Schroder, N.; Bromberg, E. Effects of increased opportunity for physical exercise and learning experiences on recognition memory and brain-derived neurotrophic factor levels in brain and serum of rats. Neuroscience 2011, 199, 284–291, doi:10.1016/j.neuroscience.2011.08.012.
  17. Langdon, K.D.; Corbett, D. Improved working memory following novel combinations of physical and cognitive activity. Neurorehabil. Neural Repair 2012, 26, 523–532, doi:10.1177/1545968311425919.
  18. Pietrelli, A.; Lopez-Costa, J.; Goni, R.; Brusco, A.; Basso, N. Aerobic exercise prevents age-dependent cognitive decline and reduces anxiety-related behaviors in middle-aged and old rats. Neuroscience 2012, 202, 252–266.
  19. Akhavan, M.M.; Emami-Abarghoie, M.; Sadighi-Moghaddam, B.; Safari, M.; Yousefi, Y.; Rashidy-Pour, A. Hippocampalangiotensin II receptors play an important role in mediating the effect of voluntary exercise on learning and memory in rat. Brain Res. 2008, 1232, 132–138, doi:10.1016/j.brainres.2008.07.042.
  20. Liu, Y.F.; Chen, H.I.; Yu, L.; Kuo, Y.M.; Wu, F.S.; Chuang, J.I.; Liao, P.C.; Jen, C.J. Upregulation of hippocampalTrkB and synaptotagmin is involved in treadmill exercise-enhanced aversive memory in mice. Neurobiol. Learn. Mem. 2008, 90, 81–89, doi:10.1016/j.nlm.2008.02.005.
  21. Aguiar, A.S., Jr.; Speck, A.E.; Prediger, R.D.; Kapczinski, F.; Pinho, R.A. Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels. J. Neural Transm. 2008, 115, 1251–1255.
  22. Yau, S.Y.; Lau, B.W.; Tong, J.B.; Wong, R.; Ching, Y.P.; Qiu, G.; Tang, S.W.; Lee, T.M.; So, K.F. Hippocampalneurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PloSOne 2011, 6, e24263.
  23. Nakajima, S.; Ohsawa, I.; Ohta, S.; Ohno, M.; Mikami, T. Regular voluntary exercise cures stress-induced impairment of cognitive function and cell proliferation accompanied by increases in cerebral IGF-1 and GST activity in mice. Behav. Brain Res. 2010, 211, 178–184.
  24. Buchman, A.S.; Boyle, P.A.; Yu, L.; Shah, R.C.; Wilson, R.S.; Bennett, D.A. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012, 78, 1323–1324.
  25. Geda, Y.E.; Roberts, R.O.; Knopman, D.S.; Christianson, T.J.; Pankratz, V.S.; Ivnik, R.J.; Boeve, B.F.; Tangalos, E.G.; Petersen, R.C.; Rocca, W.A. Physical exercise, aging, and mild cognitive impairment: A population-based study. Arch. Neurol. 2010, 67, 80–86.
  26. Liu, R.; Sui, X.; Laditka, J.N.; Church, T.S.; Colabianchi, N.; Hussey, J.; Blair, S.N. Cardiorespiratory fitness as a predictor of dementia mortality in men and women. Med. Sci. Sports Exerc. 2012, 44, 253–259.
  27. Middleton, L.E.; Mitnitski, A.; Fallah, N.; Kirkland, S.A.; Rockwood, K. Changes in cognition and mortality in relation to exercise in late life: A population based study. PloSOne 2008, 3, e3124.
  28. Yaffe, K.; Barnes, D.; Nevitt, M.; Lui, L.Y.; Covinsky, K. A prospective study of physical activity and cognitive decline in elderly women: Women who walk. Arch. Intern. Med. 2001, 161, 1703–1708, doi:10.1001/archinte.161.14.1703.
  29. Andel, R.; Crowe, M.; Pedersen, N.L.; Fratiglioni, L.; Johansson, B.; Gatz, M. Physical exercise at midlife and risk of dementia three decades later: A population-based study of swedish twins. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63, 62–66.
  30. Etgen, T.; Sander, D.; Huntgeburth, U.; Poppert, H.; Forstl, H.; Bickel, H. Physical activity and incident cognitive impairment in elderly persons: The invade study. Arch. Intern. Med. 2010, 170, 186–193.
  31. Middleton, L.E.; Barnes, D.E.; Lui, L.Y.; Yaffe, K. Physical activity over the life course and its association with cognitive performance and impairment in old age. J. Am. Geriatr. Soc. 2010, 58, 1322–1326.
  32. Landi, F.; Russo, A.; Barillaro, C.; Cesari, M.; Pahor, M.; Danese, P.; Bernabei, R.; Onder, G. Physical activity and risk of cognitive impairment among older persons living in the community. Aging Clin. Exp. Res. 2007, 19, 410–416.
  33. Tierney, M.C.; Moineddin, R.; Morra, A.; Manson, J.; Blake, J. Intensity of recreational physical activity throughout life and later life cognitive functioning in women. J. Alzheimers Dis. 2010, 22, 1331–1338.
  34. Winker, R.; Lukas, I.; Perkmann, T.; Haslacher, H.; Ponocny, E.; Lehrner, J.; Tscholakoff, D.; Dal-Bianco, P. Cognitive function in elderly marathon runners: Cross-sectional data from the marathon trial (APSOEM). Wien. Klin. Wochenschr. 2010, 122, 704–716, doi:10.1007/s00508-010-1485-z.
  35. Arntzen, K.A.; Schirmer, H.; Wilsgaard, T.; Mathiesen, E.B. Impact of cardiovascular risk factors on cognitive function: The Tromso study. Eur. J. Neurol. 2011, 18, 737–743.
  36. Brummelman, P.; Sattler, M.G.; Meiners, L.C.; Elderson, M.F.; Dullaart, R.P.; van den Berg, G.; Koerts, J.; Tucha, O.; Wolffenbuttel, B.H.; van den Bergh, A.C.; et al. Cognitive performance after postoperative pituitary radiotherapy: A dosimetric study of the hippocampus and the prefrontal cortex. Eur. J. Endocrinol. 2012, 166, 171–179.
  37. Larson, E.B.; Wang, L.; Bowen, J.D.; McCormick, W.C.; Teri, L.; Crane, P.; Kukull, W. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 2006, 144, 73–81.
  38. Middleton, L.E.; Manini, T.M.; Simonsick, E.M.; Harris, T.B.; Barnes, D.E.; Tylavsky, F.; Brach, J.S.; Everhart, J.E.; Yaffe, K. Activity energy expenditure and incident cognitive impairment in older adults. Arch. Intern. Med. 2011, 171, 1251–1257, doi:10.1001/archinternmed.2011.277.
  39. Weuve, J.; Kang, J.H.; Manson, J.E.; Breteler, M.M.; Ware, J.H.; Grodstein, F. Physical activity, including walking, and cognitive function in older women. JAMA 2004, 292, 1454–1461.
  40. Hamer, M.; Chida, Y. Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence. Psychol. Med. 2009, 39, 3–11.
  41. Erickson, K.I.; Prakash, R.S.; Voss, M.W.; Chaddock, L.; Hu, L.; Morris, K.S.; White, S.M.; Wojcicki, T.R.; McAuley, E.; Kramer, A.F. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009, 19, 1030–1039, doi:10.1002/hipo.20547.
  42. Erickson, K.I.; Weinstein, A.M.; Sutton, B.P.; Prakash, R.S.; Voss, M.W.; Chaddock, L.; Szabo, A.N.; Mailey, E.L.; White, S.M.; Wojcicki, T.R.; et al. Beyond vascularization: Aerobic fitness is associated with n-acetylaspartate and working memory. Brain Behav. 2012, 2, 32–41.
  43. Honea, R.A.; Thomas, G.P.; Harsha, A.; Anderson, H.S.; Donnelly, J.E.; Brooks, W.M.; Burns, J.M. Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2009, 23, 188–197.
  44. Bassett, D.R., Jr.; Howley, E.T. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med. Sci. Sports Exerc. 2000, 32, 70–84.
  45. McCullough, P.A.; Franklin, B.A.; Leifer, E.; Fonarow, G.C. Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure. Am. J. Nephrol. 2010, 32, 226–233, doi:10.1159/000317544.
  46. Smith, P.J.; Blumenthal, J.A.; Hoffman, B.M.; Cooper, H.; Strauman, T.A.; Welsh-Bohmer, K.; Browndyke, J.N.; Sherwood, A. Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials. Psychosom. Med. 2010, 72, 239–252.
  47. Baker, L.D.; Frank, L.L.; Foster-Schubert, K.; Green, P.S.; Wilkinson, C.W.; McTiernan, A.; Cholerton, B.A.; Plymate, S.R.; Fishel, M.A.; Watson, G.S.; et al. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer’s disease. J. Alzheimers Dis. 2010, 22, 569–579.
  48. Baker, L.D.; Frank, L.L.; Foster-Schubert, K.; Green, P.S.; Wilkinson, C.W.; McTiernan, A.; Plymate, S.R.; Fishel, M.A.; Watson, G.S.; Cholerton, B.A.; et al. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch. Neurol. 2010, 67, 71–79.
  49. Lautenschlager, N.T.; Cox, K.L.; Flicker, L.; Foster, J.K.; van Bockxmeer, F.M.; Xiao, J.; Greenop, K.R.; Almeida, O.P. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 2008, 300, 1027–1037.
  50. Williamson, J.D.; Espeland, M.; Kritchevsky, S.B.; Newman, A.B.; King, A.C.; Pahor, M.; Guralnik, J.M.; Pruitt, L.A.; Miller, M.E.; Investigators, L.S. Changes in cognitive function in a randomized trial of physical activity: Results of the lifestyle interventions and independence for elders pilot study. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64, 688–694.
  51. Erickson, K.I.; Voss, M.W.; Prakash, R.S.; Basak, C.; Szabo, A.; Chaddock, L.; Kim, J.S.; Heo, S.; Alves, H.; White, S.M.; et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. USA 2011, 108, 3017–3022.
  52. Colcombe, S.J.; Erickson, K.I.; Scalf, P.E.; Kim, J.S.; Prakash, R.; McAuley, E.; Elavsky, S.; Marquez, D.X.; Hu, L.; Kramer, A.F. Aerobic exercise training increases brain volume in aging humans. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61, 1166–1170, doi:10.1093/gerona/61.11.1166.
  53. Pajonk, F.G.; Wobrock, T.; Gruber, O.; Scherk, H.; Berner, D.; Kaizl, I.; Kierer, A.; Muller, S.; Oest, M.; Meyer, T.; et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch. Gen. Psychiatry 2010, 67, 133–143.
  54. Parker, B.A.; Thompson, P.D.; Jordan, K.C.; Grimaldi, A.S.; Assaf, M.; Jagannathan, K.; Pearlson, G.D. Effect of exercise training on hippocampal volume in humans: A pilot study. Res. Q. Exerc. Sport 2011, 82, 585–591.
  55. Liu-Ambrose, T.; Nagamatsu, L.S.; Graf, P.; Beattie, B.L.; Ashe, M.C.; Handy, T.C. Resistance training and executive functions: A 12-month randomized controlled trial. Arch. Intern. Med. 2010, 170, 170–178, doi:10.1001/archinternmed.2009.494.
  56. Cassilhas, R.C.; Viana, V.A.; Grassmann, V.; Santos, R.T.; Santos, R.F.; Tufik, S.; Mello, M.T. The impact of resistance exercise on the cognitive function of the elderly. Med. Sci. Sports Exerc. 2007, 39, 1401–1407.
  57. Perrig-Chiello, P.; Perrig, W.J.; Ehrsam, R.; Staehelin, H.B.; Krings, F. The effects of resistance training on well-being and memory in elderly volunteers. Age Ageing 1998, 27, 469–475, doi:10.1093/ageing/27.4.469.
  58. Kimura, K.; Obuchi, S.; Arai, T.; Nagasawa, H.; Shiba, Y.; Wantanabe, S.; Kojima, S. The influence of short-term strength training on health-related quality of life and executive cognitive function. J. Physiol. Anthro. 2010, 29, 95–101.
  59. Lou, S.J.; Liu, J.Y.; Chang, H.; Chen, P.J. Hippocampalneurogenesis and gene expression depend on exercise intensity in juvenile rats. Brain Res. 2008, 1210, 48–55.
  60. Bayod, S.; Del Valle, J.; Canudas, A.M.; Lalanza, J.F.; Sanchez-Roige, S.; Camins, A.; Escorihuela, R.M.; Pallas, M. Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. J. Appl. Physiol. 2011, 111, 1380–1390.
  61. Pervaiz, N.; Hoffman-Goetz, L. Freewheel training alters mouse hippocampal cytokines. Int. J. Sports Med. 2011, 32, 889–895.
  62. Santin, K.; da Rocha, R.F.; Cechetti, F.; Quincozes-Santos, A.; de Souza, D.F.; Nardin, P.; Rodrigues, L.; Leite, M.C.; Moreira, J.C.; Salbego, C.G.; et al. Moderate exercise training and chronic caloric restriction modulate redox status in rat hippocampus. Brain Res. 2011, 1421, 1–10, doi:10.1016/j.brainres.2011.08.003.
  63. Ferreira, A.F.; Real, C.C.; Rodrigues, A.C.; Alves, A.S.; Britto, L.R. Short-term, moderate exercise is capable of inducing structural, BDNF-independent hippocampal plasticity. Brain Res. 2011, 1425, 111–122, doi:10.1016/j.brainres.2011.10.004.
  64. Rodrigues, L.; Dutra, M.F.; Ilha, J.; Biasibetti, R.; Quincozes-Santos, A.; Leite, M.C.; Marcuzzo, S.; Achaval, M.; Goncalves, C.A. Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J. Neural Transm. 2010, 117, 1295–1305.
  65. Garcia-Mesa, Y.; Lopez-Ramos, J.C.; Gimenez-Llort, L.; Revilla, S.; Guerra, R.; Gruart, A.; Laferla, F.M.; Cristofol, R.; Delgado-Garcia, J.M.; Sanfeliu, C. Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J. Alzheimers Dis. 2011, 24, 421–454.
  66. Van den Berg, E.; Kessels, R.P.; de Haan, E.H.; Kappelle, L.J.; Biessels, G.J. Mild impairments in cognition in patients with type 2 diabetes mellitus: The use of the concepts MCI and CIND. J. Neurol. Neurosurg. Psychiatry 2005, 76, 1466–1467.
  67. Catlow, B.J.; Rowe, A.R.; Clearwater, C.R.; Mamcarz, M.; Arendash, G.W.; Sanchez-Ramos, J. Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1/APP mice. Brain Res. 2009, 1256, 173–179.
  68. Van Praag, H.; Shubert, T.; Zhao, C.; Gage, F.H. Exercise enhances learning and hippocampalneurogenesis in aged mice. J. Neurosci. 2005, 25, 8680–8685.
  69. Latimer, C.S.; Searcy, J.L.; Bridges, M.T.; Brewer, L.D.; Popovic, J.; Blalock, E.M.; Landfield, P.W.; Thibault, O.; Porter, N.M. Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PloSOne 2011, 6, e26812.
  70. Prakash, R.S.; Snook, E.M.; Motl, R.W.; Kramer, A.F. Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res. 2010, 1341, 41–51, doi:10.1016/j.brainres.2009.06.063.
  71. Angevaren, M.; Aufdemkampe, G.; Verhaar, H.J.; Aleman, A.; Vanhees, L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst. Rev. 2008, doi:10.1002/14651858.CD005381.pub3.
  72. Etnier, J.L.; Nowell, P.M.; Landers, D.M.; Sibley, B.A. A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res. Rev. 2006, 52, 119–130.
  73. Bookheimer, S.Y.; Strojwas, M.H.; Cohen, M.S.; Saunders, A.M.; Pericak-Vance, M.A.; Mazziotta, J.C.; Small, G.W. Patterns of brain activation in people at risk for Alzheimer’s disease. N. Engl. J. Med. 2000, 343, 450–456, doi:10.1056/NEJM200008173430701.
  74. Johnson, K.A.; Fox, N.C.; Sperling, R.A.; Klunk, W.E. Brain imaging in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2, doi:10.1101/cshperspect.a006213.
  75. Miller, S.L.; Fenstermacher, E.; Bates, J.; Blacker, D.; Sperling, R.A.; Dickerson, B.C. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J. Neurol. Neurosurg. Psychiatry 2008, 79, 630–635.
  76. Vannini, P.; Almkvist, O.; Dierks, T.; Lehmann, C.; Wahlund, L.O. Reduced neuronal efficacy in progressive mild cognitive impairment: A prospective fmri study on visuospatial processing. Psychiatry Res. 2007, 156, 43–57, doi:10.1016/j.pscychresns.2007.02.003.
  77. Colcombe, S.J.; Kramer, A.F.; Erickson, K.I.; Scalf, P.; McAuley, E.; Cohen, N.J.; Webb, A.; Jerome, G.J.; Marquez, D.X.; Elavsky, S. Cardiovascular fitness, cortical plasticity, and aging. Proc. Natl. Acad. Sci. USA 2004, 101, 3316–3321.
  78. Holzschneider, K.; Wolbers, T.; Roder, B.; Hotting, K. Cardiovascular fitness modulates brain activation associated with spatial learning. Neuroimage 2012, 59, 3003–3014.
  79. Cassilhas, R.C.; Lee, K.S.; Fernandes, J.; Oliveira, M.G.; Tufik, S.; Meeusen, R.; de Mello, M.T. Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience 2012, 202, 309–317.
  80. Cheng, G.; Huang, C.; Deng, H.; Wang, H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern. Med. J. 2012, 42, 484–491.
  81. Gold, S.M.; Dziobek, I.; Sweat, V.; Tirsi, A.; Rogers, K.; Bruehl, H.; Tsui, W.; Richardson, S.; Javier, E.; Convit, A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50, 711–719.
  82. Bruehl, H.; Sweat, V.; Tirsi, A.; Shah, B.; Convit, A. Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions. Neurosci. Med. 2011, 2, 34–42.
  83. Den Heijer, T.; Vermeer, S.E.; van Dijk, E.J.; Prins, N.D.; Koudstaal, P.J.; Hofman, A.; Breteler, M.M. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003, 46, 1604–1610, doi:10.1007/s00125-003-1235-0.
  84. Hayashi, K.; Kurioka, S.; Yamaguchi, T.; Morita, M.; Kanazawa, I.; Takase, H.; Wada, A.; Kitagaki, H.; Nagai, A.; Bokura, H.; et al. Association of cognitive dysfunction with hippocampal atrophy in elderly japanese people with type 2 diabetes. Diabetes Res. Clin. Pract. 2011, 94, 180–185.
  85. Korf, E.S.; White, L.R.; Scheltens, P.; Launer, L.J. Midlife blood pressure and the risk of hippocampal atrophy: The honoluluasia aging study. Hypertension 2004, 44, 29–34.
  86. Korf, E.S.; White, L.R.; Scheltens, P.; Launer, L.J. Brain aging in very old men with type 2 diabetes: The Honolulu-Asia aging study. Diabetes Care 2006, 29, 2268–2274, doi:10.2337/dc06-0243.
  87. Qiu, A.; Taylor, W.D.; Zhao, Z.; MacFall, J.R.; Miller, M.I.; Key, C.R.; Payne, M.E.; Steffens, D.C.; Krishnan, K.R. Apoe related hippocampal shape alteration in geriatric depression. Neuroimage 2009, 44, 620–626.
  88. Steffens, D.C.; McQuoid, D.R.; Payne, M.E.; Potter, G.G. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am. J. Geriatr. Psychiatry 2011, 19, 4–12, doi:10.1097/JGP.0b013e3181d6c245.
  89. Videbech, P.; Ravnkilde, B. Hippocampal volume and depression: A meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161, 1957–1966.
  90. Zhao, Z.; Taylor, W.D.; Styner, M.; Steffens, D.C.; Krishnan, K.R.; MacFall, J.R. Hippocampus shape analysis and late-life depression. PloSOne 2008, 3, e1837.
  91. Barnes, D.E.; Yaffe, K.; Byers, A.L.; McCormick, M.; Schaefer, C.; Whitmer, R.A. Midlife vs. late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia. Arch. Gen. Psychiatry 2012, 69, 493–498.
  92. Sachs-Erisson, N.; Sawyer, K.; Corsentino, E.; Collins, N.; Steffens, D.C. The moderating effect of the apoe small element of 4 allele on the relationship between hippocampal volume and cognitive decline in older depressed patients. Am. J. Geriatr. Psychiatry 2011, 19, 23–32.
  93. Steffens, D.C.; Payne, M.E.; Greenberg, D.L.; Byrum, C.E.; Welsh-Bohmer, K.A.; Wagner, H.R.; MacFall, J.R. Hippocampal volume and incident dementia in geriatric depression. Am. J. Geriatr. Psychiatry 2002, 10, 62–71.
  94. Ho, A.J.; Raji, C.A.; Becker, J.T.; Lopez, O.L.; Kuller, L.H.; Hua, X.; Lee, S.; Hibar, D.; Dinov, I.D.; Stein, J.L.; et al. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol. Aging 2010, 31, 1326–1339.
  95. Jagust, W.; Harvey, D.; Mungas, D.; Haan, M. Central obesity and the aging brain. Arch. Neurol. 2005, 62, 1545–1548.
  96. Raji, C.A.; Ho, A.J.; Parikshak, N.N.; Becker, J.T.; Lopez, O.L.; Kuller, L.H.; Hua, X.; Leow, A.D.; Toga, A.W.; Thompson, P.M. Brain structure and obesity. Hum. Brain Mapp. 2010, 31, 353–364.
  97. Taki, Y.; Kinomura, S.; Sato, K.; Inoue, K.; Goto, R.; Okada, K.; Uchida, S.; Kawashima, R.; Fukuda, H. Relationship between body mass index and gray matter volume in 1428 healthy individuals. Obesity 2008, 16, 119–124.
  98. Den Heijer, T.; Launer, L.J.; Prins, N.D.; van Dijk, E.J.; Vermeer, S.E.; Hofman, A.; Koudstaal, P.J.; Breteler, M.M. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005, 64, 263–267.
  99. Di Paola, M.; Caltagirone, C.; Fadda, L.; Sabatini, U.; Serra, L.; Carlesimo, G.A. Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 2008, 18, 719–728.
  100. Fotuhi, M.; Do, D.; Jack, C. Modifiable factors that alter the size of the hippocampus with ageing. Nat. Rev. Neurol. 2012, 8, 189–202.
  101. Fujioka, M.; Nishio, K.; Miyamoto, S.; Hiramatsu, K.I.; Sakaki, T.; Okuchi, K.; Taoka, T.; Fujioka, S. Hippocampal damage in the human brain after cardiac arrest. Cerebrovasc. Dis. 2000, 10, 2–7.
  102. Horstmann, A.; Frisch, S.; Jentzsch, R.T.; Muller, K.; Villringer, A.; Schroeter, M.L. Resuscitating the heart but losing the brain: Brain atrophy in the aftermath of cardiac arrest. Neurology 2010, 74, 306–312.
  103. Briones, T.L.; Woods, J. Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci. 2011, 12, 124.
  104. Winocur, G.; Henkelman, M.; Wojtowicz, J.M.; Zhang, H.; Binns, M.A.; Tannock, I.F. The effects of chemotherapy on cognitive function in a mouse model: A prospective study. Clin. Cancer Res. 2012, 18, 3112–3121, doi:10.1158/1078-0432.CCR-12-0060.
  105. Davis, J.C.; Marra, C.A.; Beattie, B.L.; Robertson, M.C.; Najafzadeh, M.; Graf, P.; Nagamatsu, L.S.; Liu-Ambrose, T. Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: A 1-year follow-up study of the brain power study. Arch. Intern. Med. 2010, 170, 2036–2038, doi:10.1001/archinternmed.2010.462.
  106. Eddy, C.M.; Rickards, H.E.; Cavanna, A.E. The cognitive impact of antiepileptic drugs. Ther. Adv. Neurol. Disord. 2011, 4, 385–407, doi:10.1177/1756285611417920.
  107. Fox, C.; Richardson, K.; Maidment, I.D.; Savva, G.M.; Matthews, F.E.; Smithard, D.; Coulton, S.; Katona, C.; Boustani, M.A.; Brayne, C. Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. J. Am. Geriatr. Soc. 2011, 59, 1477–1483, doi:10.1111/j.1532-5415.2011.03491.x.
  108. Nebes, R.D.; Pollock, B.G.; Perera, S.; Halligan, E.M.; Saxton, J.A. The greater sensitivity of elderly APOE epsilon4 carriers to anticholinergic medications is independent of cerebrovascular disease risk. Am. J. Geriatr. Pharmacother. 2012, 10, 185–192.
  109. Wagstaff, L.R.; Mitton, M.W.; Arvik, B.M.; Doraiswamy, P.M. Statin-associated memory loss: Analysis of 60 case reports and review of the literature. Pharmacotherapy 2003, 23, 871–880.
  110. King, D.S.; Wilburn, A.J.; Wofford, M.R.; Harrell, T.K.; Lindley, B.J.; Jones, D.W. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003, 23, 1663–1667.
  111. Muldoon, M.F.; Barger, S.D.; Ryan, C.M.; Flory, J.D.; Lehoczky, J.P.; Matthews, K.A.; Manuck, S.B. Effects of lovastatin on cognitive function and psychological well-being. Am. J. Med. 2000, 108, 538–546.
  112. Muldoon, M.F.; Ryan, C.M.; Sereika, S.M.; Flory, J.D.; Manuck, S.B. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am. J. Med. 2004, 117, 823–829.
  113. Ancelin, M.L.; Carriere, I.; Barberger-Gateau, P.; Auriacombe, S.; Rouaud, O.; Fourlanos, S.; Berr, C.; Dupuy, A.M.; Ritchie, K. Lipid lowering agents, cognitive decline, and dementia: The three-city study. J. Alzheimers Dis. 2012, 30, 629–637.
  114. Bettermann, K.; Arnold, A.M.; Williamson, J.; Rapp, S.; Sink, K.; Toole, J.F.; Carlson, M.C.; Yasar, S.; Dekosky, S.; Burke, G.L. Statins, risk of dementia, and cognitive function: Secondary analysis of the ginkgo evaluation of memory study. J. Stroke Cerebrovasc. Dis. 2011, 21, 436–444.
  115. Levine, D.A.; Langa, K.M. Vascular cognitive impairment: Disease mechanisms and therapeutic implications. Neurotherapeutics 2011, 8, 361–373.
  116. Tendolkar, I.; Enajat, M.; Zwiers, M.P.; van Wingen, G.; de Leeuw, F.E.; van Kuilenburg, J.; Bouwels, L.; Pop, G.; Pop-Purceleanu, M. One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: Evidence from a parallel group randomized trial. Int. J. Geriatr. Psychiatry 2012, 27, 49–58, doi:10.1002/gps.2688.
  117. Carlsson, C.M.; Xu, G.; Wen, Z.; Barnet, J.H.; Blazel, H.M.; Chappell, R.J.; Stein, J.H.; Asthana, S.; Sager, M.A.; Alsop, D.C.; et al. Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer’s disease: A pilot study. Curr. Alzheimer Res. 2011, 9, 990–997.
  118. Kurata, T.; Miyazaki, K.; Kozuki, M.; Morimoto, N.; Ohta, Y.; Ikeda, Y.; Abe, K. Progressive neurovascular disturbances in the cerebral cortex of Alzheimer’s disease-model mice: Protection by atorvastatin and pitavastatin. Neuroscience 2011, 197, 358–368, doi:10.1016/j.neuroscience.2011.09.030.
  119. Tong, X.K.; Lecrux, C.; Hamel, E. Age-dependent rescue by simvastatin of Alzheimer’s disease cerebrovascular and memory deficits. J. Neurosci. 2012, 32, 4705–4715, doi:10.1523/JNEUROSCI.0169-12.2012.
  120. Longenberger, J.; Shah, Z.A. Simvastatin and other hmg-coareductase inhibitors on brain cholesterol levels in Alzheimer’s disease. Curr. Alzheimer Res. 2011, 8, 434–442.
  121. Pac-Soo, C.; Lloyd, D.G.; Vizcaychipi, M.P.; Ma, D. Statins: The role in the treatment and prevention of Alzheimer’s neurodegeneration. J. Alzheimers Dis. 2011, 27, 1–10.
  122. Shepardson, N.E.; Shankar, G.M.; Selkoe, D.J. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch. Neurol. 2011, 68, 1385–1392.
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert